# SanofiFollowUpTreamentEmail


This email is part of a treatement journey for patients over the age of twelve that have taken more than two treatmentws of REZUROCK®. This email follow a typical transactional email conventions and includes regulatory and safety sections required for pharmaceutical communications.

> **Audience:** Patients (US residents) **12 years and older** with chronic GVHD after ≥2 prior systemic treatments.

## Features ##

- **Compliance Helpers**: CAN-SPAM footer, unsubscribe link, link tracking opt-out.
- **Accessibility**: WCAG AA-aligned HTML and plaintext alternatives.
- **Responsive Design**: Mobile-friendly layout tested across major email clients.
- Pixel tracking
